Vaccine Logistics Market Size
| Study Period | 2020 - 2029 |
| Market Size (2024) | USD 3.13 Billion |
| Market Size (2029) | USD 4.04 Billion |
| CAGR (2024 - 2029) | 5.24 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | Europe |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Vaccine Logistics Market Analysis
The Vaccine Logistics Market size is estimated at USD 3.13 billion in 2024, and is expected to reach USD 4.04 billion by 2029, growing at a CAGR of 5.20% during the forecast period (2024-2029).
New vaccines, evolving immunization schedules, innovative service delivery strategies, a broader target population, heightened cold-chain infrastructure demands, and limited funding are reshaping the dynamics of the vaccine transportation market.
Climate change has significantly altered the landscape of infectious diseases. Rising temperatures are broadening the habitats of disease vectors like mosquitoes and ticks, facilitating the spread of diseases such as malaria, dengue fever, and Lyme disease. This pattern, alongside extreme weather events and ecosystem disruptions, heightens the risk of zoonotic diseases, waterborne illnesses, and respiratory infections, underscoring the growing demand for vaccines.
For example, the Pfizer-BioNTech Vaccine mandates storage in specialized temperature-controlled thermal shippers, requiring ultra-low temperatures between -112°F and -76°F (-80°C to -60°C). Similarly, while the Moderna Vaccine doesn't demand the extreme temperatures of its Pfizer counterpart, it still requires storage at -4°F (-20°C). This vaccine must be transported directly from the manufacturing facility to its point of use, avoiding any prolonged exposure to elevated temperatures.
Transporting temperature-sensitive vaccines stands out as a particularly challenging endeavor among pharmaceuticals. These vital products necessitate meticulous handling throughout the supply chain, relying on precisely coordinated temperature-controlled logistics. Maintaining a consistent temperature is crucial, vaccines must remain within a specified range from production to administration. Deviating from this range jeopardizes the vaccine's potency and its protective efficacy against targeted diseases.
Moreover, the vaccine transportation market faces numerous challenges due to evolving vaccine requirements, climate change impacts, and stringent temperature control needs. Addressing these challenges is crucial to ensuring the efficacy and safety of vaccines worldwide.
Vaccine Logistics Market Trends
Growth and Transformation in the North American Vaccine Logistics Market
The North American vaccine logistics market is witnessing growth, primarily fueled by the surging demand for temperature-controlled transportation and storage solutions. Logistic providers are bolstering their cold chain capabilities to ensure vaccines retain their efficacy during transit. For example, FedEx has broadened its network of temperature-controlled facilities throughout the U.S., facilitating the efficient handling of vaccines that adhere to stringent temperature regulations. This strategic move not only addresses logistical challenges but also significantly enhances its cold chain capabilities, with key facilities in cities like Philadelphia and Dallas.
Furthermore, the rollout of new vaccines and the shifting immunization schedule are transforming North America's logistics landscape. In 2024, XPO has rolled out its thermally mapped transportation fleet to oversee the distribution of heat-sensitive vaccines nationwide. The company has successfully orchestrated deliveries in major cities like Chicago and Houston, guaranteeing that vaccines stay within the mandated temperature ranges from their origin to healthcare providers.
In conclusion, the North American vaccine logistics market is evolving rapidly, driven by advancements in cold chain technology and the introduction of new vaccines. Companies are also ensuring efficient and reliable vaccine distribution across the region.
Cold Chain Innovations in Vaccine Logistics Services
First, the demand for cold chain solutions is on the rise. Over the past decade from 2024, investments in the cold chain logistics sector have surged. As reported by the Biopharma Cold Chain Sourcebook, in 2020, temperature-controlled logistics made up nearly 18% of biopharma logistics expenditures. This upward trend shows no signs of slowing down.
For instance, many vaccines, such as those for diphtheria, tetanus, pertussis (DTP), and measles, mumps, and rubella (MMR), lack thermal stability. These heat-sensitive vaccines, if not kept between 2°C and 8°C, degrade quickly due to their biological components. Consequently, they depend heavily on a multi-stage refrigerated or cold-chain distribution system.
Moreover, with the advent of advanced technologies like artificial intelligence (AI) and blockchain, the pharmaceutical sector is witnessing a crucial trend: enhanced supply chain visibility. The tracking, monitoring, and management of temperature-sensitive products now generate more data than ever. Technologies that bolster this visibility not only mitigate spoilage risks but also ensure adherence to regulatory standards.
In addition, companies are innovating high-tech containers equipped with closed temperature-controlled systems. These containers facilitate the seamless transport of temperature-sensitive goods between cargo warehouses and aircraft, specifically catering to the pharmaceutical sector.
For instance, at the Port of Tyne in the UK, 5G-enabled autonomous drones have been deployed. These drones boost operational efficiency and oversee cargo handling, bolstering the cold chain by expediting processes and reducing delays for temperature-sensitive supplies.
In conclusion, the increasing demand for cold chain solutions, coupled with technological advancements, is transforming the vaccine logistics landscape. Enhanced supply chain visibility and innovative temperature-controlled systems are critical in ensuring the safe and efficient distribution of vaccines.
Vaccine Logistics Industry Overview
The vaccine logistics market is fragmented and is dominated by international companies, such as DHL Global Forwarding, AllCargo Logistics, American Airlines, FedEx Corporation and UPS Healthcare . These giants are pursuing expansion strategies, primarily through acquisitions. Their established presence allows for smoother market expansion compared to smaller players.
The demand for refrigerated warehouses, expedited delivery services, and bulk vaccine transportation is on the rise. This surge is further bolstered by heightened government investments, offering market players a chance to broaden their reach and enhance efficiency over time.
Vaccine Logistics Market Leaders
-
DHL Global Forwarding
-
AllCargo Logistics
-
American Airlines
-
FedEx Corporation
-
UPS Healthcare
*Disclaimer: Major Players sorted in no particular order
Vaccine Logistics Market News
- September 2024: Sanofi and Novavax have signed a licensing agreement to co-develop a combined flu-COVID-19 vaccine. The initiative seeks to streamline vaccine delivery and enhance worldwide accessibility, with an anticipated launch in 2025.
- August 2024: The Biomedical Advanced Research and Development Authority (BARDA) initiated "Project NextGen," channeling over 500 million USD into intranasal and oral COVID-19 vaccine platforms. This endeavor aims to bolster vaccine accessibility and adaptability, preparing for potential future pandemics.
Vaccine Logistics Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
2.1 Analysis Methodology
2.2 Research Phases
3. EXECUTIVE SUMMARY
4. MARKET INSIGHTS AND DYNAMICS
4.1 Current Market Scenario
4.2 Market Dynamics
4.2.1 Drivers
4.2.1.1 Technology innovation in temperature controlled packaging
4.2.1.2 Cross Border collaborations and initiative to enhance healthcare infrastructure
4.2.2 Restraints
4.2.2.1 Supply chain distruption and transportation bottlenecks can hinder timely vaccine distribution
4.2.2.2 Regulatory and Compiliance Challenges
4.2.3 Opportunities
4.2.3.1 Adoption of blockchain and IoT technology can improve transparency and tracebility
4.2.3.2 Next-Generation Vaccines
4.3 Industry Attractiveness - Porter's Five Forces Analysis
4.3.1 Bargaining Power of Suppliers
4.3.2 Bargaining Power of Consumers/Buyers
4.3.3 Threat of New Entrants
4.3.4 Threat of Substitute Products
4.3.5 Intensity of Competitive Rivalry
4.4 Technological Trends and Automation
4.5 Government Regulations and Initiatives
4.6 Industry Value Chain/Supply Chain Analysis
4.7 Spotlight on Ambient/Temperature-controlled Storage
4.8 Impact of Geopolitics and Pandemic on the Market
5. MARKET SEGMENTATION
5.1 By Service
5.1.1 Transportation
5.1.1.1 Land (Road and Rail)
5.1.1.2 Air
5.1.1.3 Sea
5.1.2 Warehousing
5.1.3 Value-added Services (Packaging, Labeling, etc.)
5.2 By End User
5.2.1 Hospitals
5.2.2 Drug Manufacturers and Distributors
5.2.3 Other End Users (Blood Banks, Clinics, etc.)
5.3 By Geography
5.3.1 Asia-Pacific
5.3.1.1 China
5.3.1.2 Japan
5.3.1.3 Australia
5.3.1.4 India
5.3.1.5 Singapore
5.3.1.6 Malaysia
5.3.1.7 Indonesia
5.3.1.8 Thailand
5.3.1.9 South Korea
5.3.1.10 Rest of Asia-Pacific
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 France
5.3.2.3 United Kingdom
5.3.2.4 Italy
5.3.2.5 Rest of Europe
5.3.3 North America
5.3.3.1 United States
5.3.3.2 Canada
5.3.3.3 Mexico
5.3.4 South America
5.3.4.1 Brazil
5.3.4.2 Colombia
5.3.4.3 Argentina
5.3.4.4 Rest of South America
5.3.5 Middle East
5.3.5.1 Egypt
5.3.5.2 Qatar
5.3.5.3 Saudi Arabia
5.3.5.4 United Arab Emirates
5.3.5.5 Rest of the Middle East
6. COMPETITIVE LANDSCAPE
6.1 Market Concentration Overview
6.2 Company Profiles
6.2.1 DHL Global Forwarding
6.2.2 AllCargo Logistics
6.2.3 American Airlines
6.2.4 DB Schenker
6.2.5 FedEx Corporation
6.2.6 Kuehne Nagel
6.2.7 Nippon Express
6.2.8 Yamato Logistics
6.2.9 Americold Logistics
6.2.10 lynden international logistics
6.2.11 DP World
6.2.12 Coldman Logistics
6.2.13 Cavalier Logistics*
- *List Not Exhaustive
6.3 Other Companies
7. FUTURE OF THE MARKET
8. APPENDIX
8.1 Macroeconomic Indicators (GDP Distribution, by Activity)
8.2 Economic Statistics - Transport and Storage Sector Contribution to Economy
8.3 External Trade Statistics - Exports and Imports by Product and by Country of Destination/Origin
Vaccine Logistics Industry Segmentation
Vaccines play a crucial role in preventing and controlling infectious diseases. Within the broader pharmaceutical and healthcare logistics industry, vaccine logistics holds a significant position. The vaccine logistics market encompasses the processes and systems involved in the efficient transportation, storage, and distribution of vaccines. Global study on vaccine transportation delves into the logistics and storage facilities specifically dedicated to the worldwide transportation of vaccines. The report also covers an assessment of the global economy, emerging trends by segments and regional markets, significant changes in market dynamics, and a market overview.
The vaccine logistics market is segmented by service (transportation, warehousing, and value-added services (packaging, labeling, etc.), end user (hospitals, drug manufacturers and distributors, and other end users (blood banks, clinics, etc.)), and geography (Asia-Pacific, Europe, North America, South America, and the Middle East). The report offers market size and forecasts in value (USD) for all the above segments.
| By Service | |||||
| |||||
| Warehousing | |||||
| Value-added Services (Packaging, Labeling, etc.) |
| By End User | |
| Hospitals | |
| Drug Manufacturers and Distributors | |
| Other End Users (Blood Banks, Clinics, etc.) |
| By Geography | ||||||||||||
| ||||||||||||
| ||||||||||||
| ||||||||||||
| ||||||||||||
|
Vaccine Logistics Market Research FAQs
How big is the Vaccine Logistics Market?
The Vaccine Logistics Market size is expected to reach USD 3.13 billion in 2024 and grow at a CAGR of 5.24% to reach USD 4.04 billion by 2029.
What is the current Vaccine Logistics Market size?
In 2024, the Vaccine Logistics Market size is expected to reach USD 3.13 billion.
Who are the key players in Vaccine Logistics Market?
DHL Global Forwarding, AllCargo Logistics, American Airlines, FedEx Corporation and UPS Healthcare are the major companies operating in the Vaccine Logistics Market.
Which is the fastest growing region in Vaccine Logistics Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Vaccine Logistics Market?
In 2024, the Europe accounts for the largest market share in Vaccine Logistics Market.
What years does this Vaccine Logistics Market cover, and what was the market size in 2023?
In 2023, the Vaccine Logistics Market size was estimated at USD 2.97 billion. The report covers the Vaccine Logistics Market historical market size for years: 2020, 2021, 2022 and 2023. The report also forecasts the Vaccine Logistics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Vaccine Logistics Industry Report
Statistics for the 2024 Vaccine Logistics market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Vaccine Logistics analysis includes a market forecast outlook to for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
Vaccine Logistics Market Report Snapshots
